MDHospital C.U. Lozano Blesa, Instituto De Investigacion Sanitaria AragónZaragoza, Aragon, Spain
OC 56.5 - Mechanisms of thrombogenesis in chronic myeloid leukemia (CML) patients under treatment with ponatinib and others tyrosine kinase inhibitors
Tuesday, June 25, 202410:30 – 10:45 ICT